Literature DB >> 27594126

High-dose clopidogrel versus ticagrelor for treatment of acute coronary syndromes after percutaneous coronary intervention in CYP2C19 intermediate or poor metabolizers: a prospective, randomized, open-label, single-centre trial.

Y Zhang, Y Zhao, M Pang, Y Wu, K Zhuang, H Zhang, A Bhat.   

Abstract

Entities:  

Keywords:  CYP2C19 intermediate; high-dose clopidogrel; poor metabolizers; ticagrelor

Mesh：

Substances：

Year:  2016        PMID： 27594126     DOI： 10.2143/AC.71.3.3152091

Source DB:  PubMed          Journal:  Acta Cardiol        ISSN： 0001-5385            Impact factor:   1.718


× No keyword cloud information.
  6 in total

1.  Efficacy and safety of clopidogrel versus prasugrel and ticagrelor for coronary artery disease treatment in patients with CYP2C19 LoF alleles: a systemic review and meta-analysis.

Authors:  Ha Young Yoon; Nari Lee; Jong-Mi Seong; Hye Sun Gwak
Journal:  Br J Clin Pharmacol       Date:  2020-04-28       Impact factor: 4.335

Review 2.  Genetic testing in patients undergoing percutaneous coronary intervention: rationale, evidence and practical recommendations.

Authors:  Mattia Galli; Francesco Franchi; Fabiana Rollini; Larisa H Cavallari; Davide Capodanno; Filippo Crea; Dominick J Angiolillo
Journal:  Expert Rev Clin Pharmacol       Date:  2021-05-26       Impact factor: 4.108

Review 3.  Choosing between ticagrelor and clopidogrel following percutaneous coronary intervention: A systematic review and Meta-Analysis (2007-2017).

Authors:  Wenjun Guan; Hongtao Lu; Keping Yang
Journal:  Medicine (Baltimore)       Date:  2018-10       Impact factor: 1.817

4.  Effects of clopidogrel, prasugrel and ticagrelor on prevention of stent thrombosis in patients underwent percutaneous coronary intervention: A network meta-analysis.

Authors:  Wenwen Chen; Chen Zhang; Jian Zhao; Xiuxiu Xu; Heqin Dang; Qiang Xiao; Yuanmin Li; Haifeng Hou
Journal:  Clin Cardiol       Date:  2021-03-11       Impact factor: 2.882

Review 5.  A review of the effects of ticagrelor on adenosine concentration and its clinical significance.

Authors:  Mohammed Ahmed Akkaif; Mei Li Ng; Muhamad Ali Sk Abdul Kader; Nur Aizati Athirah Daud; Abubakar Sha'aban; Baharudin Ibrahim
Journal:  Pharmacol Rep       Date:  2021-07-20       Impact factor: 3.024

6.  Comparison of Efficacy between Clopidogrel and Ticagrelor in Patients with Acute Coronary Syndrome after Interventional Treatment and Their Effects on IL-6.

Authors:  Bin Yang; Chunyan Zheng; Haichu Yu; Rui Zhang; Shan Li; Min Len; Shanglang Cai
Journal:  Iran J Public Health       Date:  2020-02       Impact factor: 1.429
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.